Associations between hematopoietic growth factors and risks of venous thromboembolism, stroke, ischemic heart disease and myelodysplastic syndrome: findings from a large population-based cohort of women with breast cancer-Reference-Cited by-同舟云学术

Associations between hematopoietic growth factors and risks of venous thromboembolism, stroke, ischemic heart disease and myelodysplastic syndrome: findings from a large population-based cohort of women with breast cancer

Published:2016-04-08 Issue:5 Volume:27 Page:695-707
ISSN:0957-5243
Container-title:Cancer Causes & Control
language:en
Short-container-title:Cancer Causes Control

Author:

Du Xianglin L.,Zhang Yefei,Hardy Dale

Funder

Agency for Healthcare Research and Quality

Cancer Prevention and Research Institute of Texas

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10552-016-0742-5.pdf

Reference44 articles.

1. Smith TJ, Khatcheressian J, Lyman GH, Ozer H, Armitage JO, Balducci L et al (2006) 2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline. J Clin Oncol 24:3187–3205

2. Heuser M, Ganser A, Bokemeyer C (2007) Use of colony-stimulating factors for chemotherapy-associated neutropenia: review of current guidelines. American Society of Clinical Oncology; National Comprehensive Cancer Network; European Organization for Research and Treatment of Cancer. Semin Hematol 44:148–156

3. Rizzo JD, Brouwers M, Hurley P et al (2010) American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer. J Clin Oncol 28(33):4996–5010

4. Morstyn G, Campbell L, Lieschke G et al (1989) Treatment of chemotherapy-induced neutropenia by subcutaneously administered granulocyte colony-stimulating factor with optimization of dose and duration of therapy. J Clin Oncol 7:1554–1562

5. Lyman GH, Kuderer NM, Djulbegovic B (2002) Prophylactic granulocyte colony-stimulating factor in patients receiving dose-intensive cancer chemotherapy: a meta-analysis. Am J Med 112:406–411

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of recombinant human granulocyte colony-stimulating factor in development of cancer-associated venous thromboembolism in lung cancer patients who undergo chemotherapy;Frontiers in Immunology;2024-05-31

2. Scutellarin suppresses the metastasis of triple-negative breast cancer via targeting TNFα/TNFR2-RUNX1-triggered G-CSF expression in endothelial cells;Biochemical Pharmacology;2023-11

3. Incidence of stroke in the first year after diagnosis of cancer—A systematic review and meta-analysis;Frontiers in Neurology;2022-09-20

4. Contemporary breast cancer treatment-associated thrombosis;Thrombosis Research;2022-05

5. Women, thrombosis, and cancer;Thrombosis Research;2019-09